AW
CLB icon

Ankerstar Wealth’s Core Laboratories CLB Stock Holding History

Ankerstar Wealth’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280 Hold
24
– – ﹤0.01% 818
2026
Q1 		$403 Hold
24
– – ﹤0.01% 671
2025
Q4 		$385 Buy
+24
New +$357 ﹤0.01% 725

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ankerstar Wealth's CLB Position: Q2 2026 in Review

Ankerstar Wealth held its Core Laboratories (CLB) position steady in Q2 2026 at 24 shares worth $280. The position accounts for ﹤0.01% of the portfolio, ranked #818.

Ankerstar Wealth first reported a position in CLB in Q4 2025 and has held it in 3 quarters since. The position peaked at $403 in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Ankerstar Wealth held 24 shares of Core Laboratories worth $280 as of Q2 2026.
  • Ankerstar Wealth left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Ankerstar Wealth's portfolio in Q2 2026, its #818 holding.
  • Ankerstar Wealth first reported a position in Core Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Ankerstar Wealth's Core Laboratories position peaked at $403 in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.